ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $38 | $9 | $8 | $7 |
| - Cash | $1 | $1 | $1 | $2 |
| + Debt | $2 | $2 | $2 | $1 |
| Enterprise Value | $39 | $9 | $8 | $6 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 341.8% | 5.9% | 651.4% | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 97% | 86.2% | 89.5% | 88.1% |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | -24.2% | -335% | -375.3% | -2,860.4% |
| Net Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | -41.3% | -417% | -421% | -2,803.4% |
| EPS Diluted | -1.34 | -13.12 | -13.4 | -12.28 |
| % Growth | 89.8% | 2.1% | -9.1% | – |
| Operating Cash Flow | -$0 | -$1 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$1 | -$1 | -$1 |